Responses
Immune cell therapies and immune cell engineering
Original research
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.